EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer

被引：0
|
作者：
Toshihiko, Yokoyama
Kondo, Masashi
Goto, Yasuhiro
Fukui, Takayuki
Yoshioka, Hiromu
Yokoi, Kohei
Kondo, Yutaka
Osada, Hirotaka
Imaizumi, Kazuyoshi
Hasegawa, Yoshinori
Shimokata, Kaoru
Sekido, Yoshitaka
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi, Japan
[2] Nagoya Univ, Dept Resp Med, Nagoya, Aichi, Japan
[3] Nagoya Univ, Dept Thorat Surg, Nagoya, Aichi, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4134
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer
    Cappuzzo, F
    Bemis, L
    Varella-Garcia, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24): : 2619 - 2621
  • [2] Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
    Hirsch, F. R.
    Varella-Garcia, M.
    Cappuzzo, F.
    ONCOGENE, 2009, 28 : S32 - S37
  • [3] Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
    F R Hirsch
    M Varella-Garcia
    F Cappuzzo
    Oncogene, 2009, 28 : S32 - S37
  • [4] HercepTest: HER2 expression and gene amplification in non-small cell lung cancer
    Cox, G
    Vyberg, M
    Melgaard, B
    Askaa, J
    Oster, A
    O'Byrne, KJ
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) : 480 - 483
  • [5] Her2 gene amplification and protein expression in non-small cell lung cancer
    Cox, G
    Vyberg, M
    Melgaard, B
    O'Byrne, KJ
    THORAX, 2000, 55 : A85 - A85
  • [6] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [7] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [8] Exclusive mutation in EGFR, HER2, and KRAS, and synchronous methylation of non-small cell lung cancer
    Suzuki, Makoto
    Shigematsu, Hisayuki
    Iizasa, Toshihiko
    Minna, John D.
    Fujisawa, Takehiko
    Gazdar, Adi F.
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Pilot evaluation of a HER2 testing in non-small-cell lung cancer
    Hotta, Katsuyuki
    Yanai, Hiroyuki
    Ohashi, Kadoaki
    Ninomiya, Kiichiro
    Nakashima, Hiromi
    Kayatani, Hiroe
    Takata, Minoru
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (06) : 353 - 357
  • [10] Consensus for HER2 alterations testing in non-small-cell lung cancer
    Ren, S.
    Wang, J.
    Ying, J.
    Mitsudomi, T.
    Lee, D. H.
    Wang, Z.
    Chu, Q.
    Mack, P. C.
    Cheng, Y.
    Duan, J.
    Fan, Y.
    Han, B.
    Hui, Z.
    Liu, A.
    Liu, J.
    Lu, Y.
    Ma, Z.
    Shi, M.
    Shu, Y.
    Song, Q.
    Song, X.
    Song, Y.
    Wang, C.
    Wang, X.
    Wang, Z.
    Xu, Y.
    Yao, Y.
    Zhang, L.
    Zhao, M.
    Zhu, B.
    Zhang, J.
    Zhou, C.
    Hirsch, F. R.
    ESMO OPEN, 2022, 7 (01)
12345